This study demonstrated that PAMAM-PEG-TfR/TMZ not only inhibited glioma growth, but also accomplished tumor regression and delayed tumor recurrence, at least in orthotopic glioma nude mouse models. This evidence concerns the gene TFRC and central nervous system cancer.